Increased interleukin 5 production in eosinophilic Sézary syndrome: Regulation by interferon alfa and interleukin 12 - 02/09/11
Abstract |
Background: Peripheral eosinophilia occurs in a small subpopulation of patients with cutaneous T-cell lymphoma (CTCL) and denotes a poor prognosis. Clinical studies have suggested that the Sézary cell is a TH2 type helper T cell that produces cytokines that enhance the differentiation and activation of eosinophils. Interferon alfa (IFN-⍺) and interleukin 12 are effective therapeutic agents for CTCL and other hematologic disorders. Objective: Our purpose was to determine the inhibitory activity of IFN-⍺ and IL-12 on IL-5 production in vitro by peripheral blood mononuclear cells (PBMCs) obtained from patients with CTCL and eosinophilia. Methods: Suppression of IL-5 production by IFN-⍺ and IL-12 was assessed by comparing IL-5 production by PBMCs from patients with Sézary syndrome and eosinophilia when cultured alone or in the presence of either IFN-⍺ or IL-12. Results: A marked increase in IL-5 production by PBMCs from patients with Sézary syndrome and eosinophilia was observed. IL-5 production was markedly reduced when PBMCs were exposed to IFN-⍺ or IL-12. Conclusion: These results suggest that IFN-⍺ and perhaps IL-12 may produce a therapeutic response in patients with CTCL and eosinophilia through direct suppression of IL-5 production by malignant Sézary cells. (J Am Acad Dermatol 2001;44:28-32.)
Le texte complet de cet article est disponible en PDF.Plan
Reprint requests: Alain Rook, MD, Department of Dermatology, Hospital of the University of Pennsylvania, 2 Rhoads Pavilion, 3600 Spruce St, Philadelphia, PA 19104-4283. |
|
J Am Acad Dermatol 2001;44:28-32. |
Vol 44 - N° 1
P. 28-32 - janvier 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?